Sequel Med Tech Launches twiist AID, Outlines Commercial Strategy
Sequel Med Tech began a limited US launch of its new twiist automated insulin delivery system in July and is working toward full launch by year’s end. In this brief Q&A, Chris Gilbert, Sequel’s VP of marketing, provides more details on the company’s competitive strategy and its future plans.
Read Article